Patents Assigned to DeveloGen Aktiengesellschaft
  • Publication number: 20050222070
    Abstract: The present invention discloses polynucleotides which identify and encode DP119, DP444, DP810, DP685, WE474, DP160, RA977, or RA770 as well as novel functions for these proteins of the inventions. The invention provides for compositions for disorders associated with the expression of the proteins of the invention, such as for the treatment, alleviation and/or prevention of pancreatic dysfunction (for example diabetes, hyperglycemia, and impaired glucose tolerance), and related disorders, and other disease and disorders.
    Type: Application
    Filed: November 29, 2004
    Publication date: October 6, 2005
    Applicant: Develogen Aktiengesellschaft fuer Entwicklungsbiologische Forschung
    Inventors: Cord Dohrmann, Matthias Austen
  • Publication number: 20050119206
    Abstract: The present invention discloses proteins regulating the energy homeostasis and the metabolism of triglycerides, and polynucleotides, which identify and encode the proteins disclosed in this invention. The invention also relates to the use of these sequences in the diagnosis, study, prevention and treatment of metabolic diseases and disorders.
    Type: Application
    Filed: March 14, 2003
    Publication date: June 2, 2005
    Applicant: DeveloGen Aktiengesellschaft fuerentwicklungsbolog
    Inventors: Karsten Eulenberg, Arnd Steuernagel, Thomas Hader, Gunter Bronner
  • Patent number: 6821777
    Abstract: The invention relates to the ovine embryo cell line HVO-156 (DSM ACC2440), or to cell lines derived therefrom, and to their use for preparing and propagating ovine adenoviruses, in particular recombinant ovine adenoviruses which are derived from the isolate OAV 287.
    Type: Grant
    Filed: July 15, 2002
    Date of Patent: November 23, 2004
    Assignee: DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung
    Inventors: Christian Hofmann, Moritz Hillgenberg, Peter Löser